Charlotte R. Bell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Charlotte R. Bell has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Eleonora Melzi
MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom
2 shared publications Kim Willoughby
2 shared publicationsMorag G. Kerr
2 shared publications- Sandra F. E. Scholes
SAC Consulting Veterinary Services, Penicuik, UK
2 shared publications C. D. Penny
Large Animal Practice Royal (Dick) School of Veterinary Studies Easter Bush Veterinary Centre Roslin Midlothian EH25 9RG
1 shared publicationD. J. Wilson
Large Animal Practice Royal (Dick) School of Veterinary Studies Easter Bush Veterinary Centre Roslin Midlothian EH25 9RG
1 shared publication
Latest Publications
- Open Access
- 31 October 2016
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 16 (1) , 65-71
The risks of using allogeneic cell lines for vaccine production: the example of Bovine Neonatal Pancytopenia
Introduction: Bovine neonatal pancytopenia (BNP) is a hemorrhagic disease that emerged in calves across Europe in 2007. Its occurrence is attributed to immunization of the calf’s mother with a vaccine produced using an allogeneic cell line. Vaccine-induced alloantibodies specific for major-histocompatibility class I antigens are transferred from the mother to the calf via colostrum, leading to profound depletion of peripheral blood and bone marrow cells that is often fatal. Areas covered: Pubmed and Web of Science were used to search for literature relevant to BNP and the use of allogeneic vaccine cell lines. Following a review of the pathology and pathogenesis of this novel condition, we discuss potential risks associated with the use of allogeneic vaccine cell lines. Expert commentary: Although BNP is associated with a specific vaccine, it highlights safety concerns common to all vaccines produced using allogeneic cell lines. Measures to prevent similar vaccine-induced alloimmune-mediated adverse events in the future are discussed.
- 31 October 2016
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 16 (1) , 65-71
Open AccessThe risks of using allogeneic cell lines for vaccine production: the example of Bovine Neonatal Pancytopenia
Introduction: Bovine neonatal pancytopenia (BNP) is a hemorrhagic disease that emerged in calves across Europe in 2007. Its occurrence is attributed to immunization of the calf’s mother with a vaccine produced using an allogeneic cell line. Vaccine-induced alloantibodies specific for major-histocompatibility class I antigens are transferred from the mother to the calf via colostrum, leading to profound depletion of peripheral blood and bone marrow cells that is often fatal. Areas covered: Pubmed and Web of Science were used to search for literature relevant to BNP and the use of allogeneic vaccine cell lines. Following a review of the pathology and pathogenesis of this novel condition, we discuss potential risks associated with the use of allogeneic vaccine cell lines. Expert commentary: Although BNP is associated with a specific vaccine, it highlights safety concerns common to all vaccines produced using allogeneic cell lines. Measures to prevent similar vaccine-induced alloimmune-mediated adverse events in the future are discussed.
- Open Access
- 8 October 2014
- Published by Springer Nature in BMC Veterinary Research
- Vol. 10 (1) , 245
Evidence of a high incidence of subclinically affected calves in a herd of cattle with fatal cases of Bovine Neonatal Pancytopenia (BNP)
Bovine Neonatal Pancytopenia (BNP) is a disease of calves characterised by bone marrow trilineage hypoplasia, mediated by ingestion of alloantibodies in colostrum. Suspected subclinical forms of BNP have been reported, suggesting that observed clinical cases may not represent the full extent of the disease. However to date there are no objective data available on the incidence of subclinical disease or its temporal distribution. This study aimed to 1) ascertain whether subclinical BNP occurs and, if so, to determine the incidence on an affected farm and 2) determine whether there is evidence of temporal clustering of BNP cases on this farm. To achieve these aims, haematological screening of calves born on the farm during one calving season was carried out, utilising blood samples collected at defined ages. These data were then analysed in comparison to data from both known BNP-free control animals and histopathologically confirmed BNP cases. An ordinal logistic regression model was used to create a composite haematology score to predict the probabilities of calves being normal, based on their haematology measurements at 10-14 days old. This study revealed that 15% (21 of 139) of the clinically normal calves on this farm had profoundly abnormal haematology (<5% chance of being normal) and could be defined as affected by subclinical BNP. Together with clinical BNP cases, this gave the study farm a BNP incidence of 18%. Calves with BNP were found to be distributed throughout the calving period, with no clustering, and no significant differences in the date of birth of cases or subclinical cases were found compared to the rest of the calves. This study did not find any evidence of increased mortality or increased time from birth to sale in subclinical BNP calves but, as the study only involved a single farm and adverse effects may be determined by other inter-current diseases it remains possible that subclinical BNP has a detrimental impact on the health and productivity of calves under certain circumstances. Subclinical BNP was found to occur at a high incidence in a herd of cattle with fatal cases of BNP.
- 8 October 2014
- Published by Springer Nature in BMC Veterinary Research
- Vol. 10 (1) , 245
Open AccessEvidence of a high incidence of subclinically affected calves in a herd of cattle with fatal cases of Bovine Neonatal Pancytopenia (BNP)
Bovine Neonatal Pancytopenia (BNP) is a disease of calves characterised by bone marrow trilineage hypoplasia, mediated by ingestion of alloantibodies in colostrum. Suspected subclinical forms of BNP have been reported, suggesting that observed clinical cases may not represent the full extent of the disease. However to date there are no objective data available on the incidence of subclinical disease or its temporal distribution. This study aimed to 1) ascertain whether subclinical BNP occurs and, if so, to determine the incidence on an affected farm and 2) determine whether there is evidence of temporal clustering of BNP cases on this farm. To achieve these aims, haematological screening of calves born on the farm during one calving season was carried out, utilising blood samples collected at defined ages. These data were then analysed in comparison to data from both known BNP-free control animals and histopathologically confirmed BNP cases. An ordinal logistic regression model was used to create a composite haematology score to predict the probabilities of calves being normal, based on their haematology measurements at 10-14 days old. This study revealed that 15% (21 of 139) of the clinically normal calves on this farm had profoundly abnormal haematology (<5% chance of being normal) and could be defined as affected by subclinical BNP. Together with clinical BNP cases, this gave the study farm a BNP incidence of 18%. Calves with BNP were found to be distributed throughout the calving period, with no clustering, and no significant differences in the date of birth of cases or subclinical cases were found compared to the rest of the calves. This study did not find any evidence of increased mortality or increased time from birth to sale in subclinical BNP calves but, as the study only involved a single farm and adverse effects may be determined by other inter-current diseases it remains possible that subclinical BNP has a detrimental impact on the health and productivity of calves under certain circumstances. Subclinical BNP was found to occur at a high incidence in a herd of cattle with fatal cases of BNP.
- 1 February 2013
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 151 (3-4) , 303-314
Reproduction of bovine neonatal pancytopenia (BNP) by feeding pooled colostrum reveals variable alloantibody damage to different haematopoietic lineages
- 1 February 2013
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 151 (3-4) , 303-314
Reproduction of bovine neonatal pancytopenia (BNP) by feeding pooled colostrum reveals variable alloantibody damage to different haematopoietic lineages
- Open Access
- 30 October 2012
- Published by Springer Nature in BMC Research Notes
- Vol. 5 (1) , 599
Demonstration of early functional compromise of bone marrow derived hematopoietic progenitor cells during bovine neonatal pancytopenia through in vitro culture of bone marrow biopsies
Background: Bovine neonatal pancytopenia (BNP) is a syndrome characterised by thrombocytopenia associated with marked bone marrow destruction in calves, widely reported since 2007 in several European countries and since 2011 in New Zealand. The disease is epidemiologically associated with the use of an inactivated bovine virus diarrhoea (BVD) vaccine and is currently considered to be caused by absorption of colostral antibody produced by some vaccinated cows (“BNP dams”). Alloantibodies capable of binding to the leukocyte surface have been detected in BNP dams and antibodies recognising bovine MHC class I and β-2-microglobulin have been detected in vaccinated cattle. In this study, calves were challenged with pooled colostrum collected from BNP dams or from non-BNP dams and their bone marrow hematopoietic progenitor cells (HPC) cultured in vitro from sternal biopsies taken at 24 hours and 6 days post-challenge. Results: Clonogenic assay demonstrated that CFU-GEMM (colony forming unit-granulocyte/erythroid/macrophage/megakaryocyte; pluripotential progenitor cell) colony development was compromised from HPCs harvested as early as 24 hour post-challenge. By 6 days post challenge, HPCs harvested from challenged calves failed to develop CFU-E (erythroid) colonies and the development of both CFU-GEMM and CFU-GM (granulocyte/macrophage) was markedly reduced. Conclusion: This study suggests that the bone marrow pathology and clinical signs associated with BNP are related to an insult which compromises the pluripotential progenitor cell within the first 24 hours of life but that this does not initially include all cell types.
- 30 October 2012
- Published by Springer Nature in BMC Research Notes
- Vol. 5 (1) , 599
Open AccessDemonstration of early functional compromise of bone marrow derived hematopoietic progenitor cells during bovine neonatal pancytopenia through in vitro culture of bone marrow biopsies
Background: Bovine neonatal pancytopenia (BNP) is a syndrome characterised by thrombocytopenia associated with marked bone marrow destruction in calves, widely reported since 2007 in several European countries and since 2011 in New Zealand. The disease is epidemiologically associated with the use of an inactivated bovine virus diarrhoea (BVD) vaccine and is currently considered to be caused by absorption of colostral antibody produced by some vaccinated cows (“BNP dams”). Alloantibodies capable of binding to the leukocyte surface have been detected in BNP dams and antibodies recognising bovine MHC class I and β-2-microglobulin have been detected in vaccinated cattle. In this study, calves were challenged with pooled colostrum collected from BNP dams or from non-BNP dams and their bone marrow hematopoietic progenitor cells (HPC) cultured in vitro from sternal biopsies taken at 24 hours and 6 days post-challenge. Results: Clonogenic assay demonstrated that CFU-GEMM (colony forming unit-granulocyte/erythroid/macrophage/megakaryocyte; pluripotential progenitor cell) colony development was compromised from HPCs harvested as early as 24 hour post-challenge. By 6 days post challenge, HPCs harvested from challenged calves failed to develop CFU-E (erythroid) colonies and the development of both CFU-GEMM and CFU-GM (granulocyte/macrophage) was markedly reduced. Conclusion: This study suggests that the bone marrow pathology and clinical signs associated with BNP are related to an insult which compromises the pluripotential progenitor cell within the first 24 hours of life but that this does not initially include all cell types.
- 11 December 2010
- Published by Wiley in Veterinary Record
- Vol. 167 (24) , 938-940
Idiopathic bovine neonatal pancytopenia in a Scottish beef herd
PANCYTOPENIA, due to hypoplastic or aplastic bone marrow, has historically been uncommon in cattle. Fatal haemorrhagic pancytopenia has been reported in cattle due to the ingestion of trichloroethylene-extracted soya oil meal (TCESOM) ([Rundles 1958][1]), bracken fern ( Pteridium species) ([Hirono
- 11 December 2010
- Published by Wiley in Veterinary Record
- Vol. 167 (24) , 938-940
Idiopathic bovine neonatal pancytopenia in a Scottish beef herd
PANCYTOPENIA, due to hypoplastic or aplastic bone marrow, has historically been uncommon in cattle. Fatal haemorrhagic pancytopenia has been reported in cattle due to the ingestion of trichloroethylene-extracted soya oil meal (TCESOM) ([Rundles 1958][1]), bracken fern ( Pteridium species) ([Hirono
- Open Access
- 6 November 2010
- Published by Wiley in Veterinary Record
- Vol. 167 (19) , 758
Possible preventive strategy for bovine neonatal pancytopenia
Click on the article title to read more.
- 6 November 2010
- Published by Wiley in Veterinary Record
- Vol. 167 (19) , 758
Open AccessPossible preventive strategy for bovine neonatal pancytopenia
Click on the article title to read more.